Skip to main content

Table 1 Clinical characteristics of study subjects

From: Impacts of plasma microbial lipopolysaccharide translocation on B cell perturbations and anti-CD4 autoantibody production in people with HIV on suppressive antiretroviral therapy

 

HIV-negative

(n = 16)

HIV+/antiCD4low

(n = 17)

HIV+/antiCD4high

(n = 8)

P value (two HIV + groups)

Age (years)

45 (37–57)

48 (38–57)

44 (37–59)

0.18

Sex ratio, male: female

7:9

12:5

5:3

0.52

CD4+ T cell counts

 

568 (359–735)

278 (96–348)

< 0.0001

Nadir CD4+ T cell counts

 

294 (157–510)

215 (101–425)

0.47

Duration of ART (years)

 

6.2 (4.3–6.9)

5.5 (4–6)

0.56

  1. ART, antiretroviral therapy; CD4 T cell count (cells/µL)
  2. Data are means (25th percentile, 75th percentile)